No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

HomeEXECUTIVES

Category: EXECUTIVES

Avation Medical adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Lazurite® Names Julia Greenspan Director of Sales Operations

Julia Greenspan has spent the last 25 years in the operating room/medical device industry in roles of increasing responsibility, from surgical technologist to senior orthopedic trauma sales representative and regional director of medical education.

Richard Pellegrino Is Appointed New Chief Research and Development Officer of Grenova

Richard Pellegrino joins Grenova during a period of rapid growth as the company expands its award-winning team designed to make the life sciences industry environmentally friendly, cost-effective, and efficient.

Organicell Appoints Harry Leider, MD, MBA as New CEO

Dr. Harry Leider brings more than 25 years of experience as a healthcare executive and entrepreneur, with extensive experience serving in C-suite roles in both publicly-held and early-stage companies, to the position. He has advanced breakthroughs in patient care across multiple sectors of the health care industry.

Lohman Technologies Welcomes Accomplished Healthcare Innovator Dr Nick Turkal to its Board of Directors

Dr Nick Turkal brings a wealth of expertise and a proven track record in the healthcare industry. Dr. Turkal’s visionary leadership, combined with a deep understanding of the dynamic healthcare landscape will contribute significantly to Lohman’s ongoing success.

IntelliGuard Appoints Robert Howard as CEO and Thomas Koning as President to Execute on Strategy of Continued Growth

The IntelliGuard leadership team was first expanded in November 2022 with the appointment of Tim Tinnell as Chief Operating Officer (COO). He joined IntelliGuard in 2019 as the Chief Customer Officer (CCO), where he was responsible for overseeing implementations, customer support, and the overall customer experience.

William A Clementi Appointed Chief Development Officer at Tiziana Life Sciences

Dr William A Clementi brings with him a wealth of experience in the biopharmaceutical industry, having held leadership roles at several prominent companies. He has a proven track record of successfully guiding development programs from early stages through clinical trials, regulatory approval, and commercialization.

Optimal Further Strengthens Operations with New Global Sales Manager, Chris Vickers

Martin Gadsby, VP at Optimal, comments: “In addition to manufacturers looking to adopt PAT, we are seeing global customers interested in expanding their PAT-driven frameworks to improve multiple lines and plants. Chris Vickers has a proven ability to engage with experts in a variety of industries and intuitively understand their requirements. These capabilities make him the ideal candidate to strengthen existing customer relationships and forge new collaborations. We are extremely delighted to have him on our team and excited to see what we can achieve together.”

Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board

Dr. Heather Landau is the Director of Amyloidosis Program and a Bone Marrow Transplant Specialist & Cellular Therapist at Memorial Sloan-Kettering Cancer Center in New York. She has authored more than 100 peer-reviewed publications.

GEDi Cube appoints Dr Lester Russell as Chief Medical Officer

Dr Lester Russell is a seasoned expert and leader in clinical medicine and digital health, Lester will be responsible for leading on clinician engagement, clinical validation, and clinical quality assurance as GEDi Cube transitions to the testing and go-to-market phase for its AI/ML platform.

By using this website you agree to accept Medical Device News Magazine Privacy Policy